A5274/REMEMBER- Reducing Early Mortality and Early Morbidity by Empiric Tuberculosis Treatment Regimens A Site-Limited Trial of the AIDS Clinical Trials Group (ACTG)
HPTN 052-A Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy Plus HIV Primary Care versus HIV Primary Care Alone to Prevent the Sexual Transmission of HIV-1 In Serodiscordant Couples
Randomized Control Trial of Structured Interrupted Generic Antiretroviral Therapy (SIT) versus Continuous Therapy (CT) in HIV-infected Individuals
Prevalence and Incidence of Sexually Transmitted Infections among South Indians at Increased Risk of HIV Infection
GSK TB 014 Project – A Phase II, Double Blind (Observer-Blind), Randomised, Controlled Study To Evaluate The Safety, Reactogenicity And Immunogenicity of GSK Biologicals’ Candidate Tuberculosis Vaccine (M72/As01e) When Administered Intramuscularly According To A 0,1 Month Schedule To HIV-Positive Adults Living In A TB Endemic Region
AMC #054 – A Single-Arm, Open-Label Pilot Study of the Safety and Immuno genicity of the Merck Quadrivalent Human Papillomavirus Vaccine among HIV-Positive Women in India: A Trial of the AIDS Malignancy: Clinical Trials Consortium (AMC).
SECONDLINE STUDY- A Randomised Open-Label Study comparing the Safety and Efficacy of Ritonavir boosted Lopinavir and 2-3N(T)RTI Backbone versus Ritonavir boosted Lopinavir and Raltegravir in Participants Virologically Failing First-Line NNRTI/2N(T)RTI Therapy
HIVIND – The Antiretroviral Roll out for HIV in India – Strengthening Capacity to Promote Adherence and Patient follow-up in the Context: A Research Plan for a Two-Centre, Randomized, Controlled, Open Trial in South India to Study an Innovative approach to Promote Adherence in HIV + Indian Patients
WRHI001-GATES- A Randomized, Double-Blind, Multi-Centre, Parallel-Group Phase 3b Study To Demonstrate Non-Inferiority Of Stavudine (20 Mg Twice Daily) Compared With Tenofovir Disoproxil Fumarate (300 Mg Once Daily) When Administered In Combination With Lamivudine And Efavirenz In Anti Retroviral-Naive Patients Infected With HIV-1
